PDI appoints new head of R&D

September 22, 2020  –  PDI, a global leader in infection prevention product and service solutions, has appointed Michael Yang, PhD, as SVP of Research and Development (R&D).

Dr. Yang will lead PDI’s growing R&D organization focusing on innovative solutions that address the critical needs of today’s healthcare, food safety, and public health markets as part of the company’s mission to prevent infections, serve its customers and, ultimately, save lives.

Dr. Yang joins PDI after holding progressively responsible R&D leadership roles in leading global companies such as Cardiovascular Systems, Johnson & Johnson, and Abbott Labs / St. Jude Medical.

Most recently, Dr. Yang was the VP, Global Product Development and Program Management Office, Specialty Surgical Division, a $1B+ division of Integra Life Sciences.

He has also served as a consultant and advisor to several established and emerging medical technology firms expanding their product portfolios and advancing their product development programs and processes.

Learn More